JO
Insider
John Oyler
Chief Executive OfficerJohn Oyler (Chief Executive Officer) filed 11 Form 4 reports in the trailing twelve months (0 purchases, 11 sales), most often in BeOne Medicines AG (ONC). The largest single filing was $89.3M of ONC (282,921 sh across 16 lots, as filed), executed Jul 15.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
11
0 buys · 11 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$327.2M
shares × price, as filed
Last traded
Aug 12
Filed Aug 12
Median ADV $130.5M across their filed names
Open performance→Volume by month
Buys $0
Sells $410.0M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
11 filings
Sector per market data · by filing · past 12 months
Most traded names
ONCRecent filings
ONCSALE
BeOne Medicines AG
View filing →
$411K1,600 sh across 2 lots
Exec Jun 11
Filed Jun 15 · 5:30 PM ET ONCSALE BeOne Medicines AG View filing → $1.3M
4,940 sh across 2 lots
Exec Jun 8
Filed Jun 10 · 5:30 PM ET ONCSALE BeOne Medicines AG View filing → $30.6M
99,839 sh across 22 lots
Exec Dec 15 2025
Filed Dec 17 2025 · 5:30 PM ET ONCSALE BeOne Medicines AG View filing → $9.1M
27,803 sh across 5 lots
Exec Sep 16 2025
Filed Sep 18 2025 · 5:30 PM ET ONCSALE BeOne Medicines AG View filing → $7.0M
27,802 sh across 4 lots
Exec Jul 9 2025
Filed Jul 11 2025 · 5:30 PM ET ONCSALE BeOne Medicines AG View filing → $804K
3,074 sh × $261.57
Exec Jun 23 2025
Filed Jun 25 2025 · 5:30 PM ET ONCSALE BeOne Medicines AG View filing → $1.4M
5,140 sh across 2 lots
Exec Jun 16 2025
Filed Jun 18 2025 · 5:30 PM ET ONCSALE BeOne Medicines AG View filing → $1.3M
5,127 sh across 5 lots
Exec Jun 6 2025
Filed Jun 10 2025 · 5:30 PM ET More filings →